Diagnostic clinical benefits of digital spot and digital 3D mammography following analysis of screening findings

Mari Lehtimaki; Martti Pamilo; Leena Raulisto; Marja Roiha; Martti Kalke; Samuli Siltanen; Timo Ihamäki

doi:10.1117/12.479578

30 May 2003 Diagnostic clinical benefits of digital spot and digital 3D mammography following analysis of screening findings

Mari Lehtimaki, Martti Pamilo, Leena Raulisto, Marja Roiha, Martti Kalke, Samuli Siltanen, Timo Ihamäki

Author Affiliations +

Proceedings Volume 5029, Medical Imaging 2003: Visualization, Image-Guided Procedures, and Display; (2003) https://doi.org/10.1117/12.479578
Event: Medical Imaging 2003, 2003, San Diego, California, United States

Abstract

The purpose of this study is to find out the impact of 3-dimensional digital mammography and digital spot imaging following analysis of the abnormal findings of screening mammograms. Over a period of eight months, digital 3-D mammography imaging TACT Tuned Aperture Computed Tomography+, digital spot imaging (DSI), screen-film mammography imaging (SFM) and diagnostic film imaging (DFM) examinations were performed on 60 symptomatic cases. All patients were recalled because it was not possible to exclude the presence of breast cancer on screening films. Abnormal findings on the screening films were non-specific tumor-like parenchymal densities, parenchymal asymmetries or distortions with or without microcalcifications or just microcalcifications. Mammography work-up (film imaging) included spot compression and microfocus magnification views. The 3-D softcopy reading in all cases was done with Delta 32 TACT mammography workstation, while the film images were read using a mammography-specific light box. During the softcopy reading only windowing tools were allowed. The result of this study indicates that the clinical diagnostic image quality of digital 3-D and digital spot images are better than in film images, even in comparison with diagnostic work-up films. Potential advantages are to define if the mammography finding is caused by a real abnormal lesion or by superimposition of normal parenchymal structures, to detect changes in breast tissue which would otherwise be missed, to verify the correct target for biopsies and to reduce the number of biopsies performed.

Citation Download Citation

Mari Lehtimaki, Martti Pamilo, Leena Raulisto, Marja Roiha, Martti Kalke, Samuli Siltanen, and Timo Ihamäki "Diagnostic clinical benefits of digital spot and digital 3D mammography following analysis of screening findings", Proc. SPIE 5029, Medical Imaging 2003: Visualization, Image-Guided Procedures, and Display, (30 May 2003); https://doi.org/10.1117/12.479578

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available